NCT03389230: Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma |
|
|
| Active, not recruiting | 1 | 29 | US | HER2(EQ)BBζ/CD19t+ T cells, Laboratory Biomarker Analysis, Leukapheresis, Leukocytopheresis, Therapeutic Leukopheresis | City of Hope Medical Center, National Cancer Institute (NCI) | Glioblastoma, Malignant Glioma, Recurrent Glioma, Refractory Glioma, WHO Grade III Glioma | 06/24 | 06/24 | | |
NCT03696030: HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases |
|
|
| Recruiting | 1 | 39 | US | Chimeric Antigen Receptor T-Cell Therapy, CAR T Infusion, CAR T Therapy, CAR T-cell therapy, Chimeric Antigen Receptor T-cell Infusion | City of Hope Medical Center, National Cancer Institute (NCI), California Institute for Regenerative Medicine (CIRM) | Malignant Neoplasm, Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Neoplasm in the Leptomeninges, Breast Cancer, HER2-positive Breast Cancer | 02/25 | 02/25 | | |
